On July 25, 2025, Intelligent Bio Solutions Inc. entered into agreements for existing warrant holders to exercise their warrants in exchange for new warrants and a lower exercise price. This transaction is expected to bring in approximately $3.8 million to fund the company's FDA filing and operations.